Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Working Capital/Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 5.175.104.845.359.40

What is the latest Working Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Working Capital/Sales ratio of AUROBINDO PHARMA is 5.17 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20245.17
Mar20235.10
Mar20224.84
Mar20215.35
Mar20209.40

How is Working Capital/Sales of AUROBINDO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 5.17
1.37
Mar2023 5.1
5.37
Mar2022 4.84
-9.53
Mar2021 5.35
-43.09
Mar2020 9.4 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Working Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,082.4 Cr -0.5% -5.3% -8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.4% -1.2% 12.2% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 2.6% 8.4% 48.5% Stock Analytics
CIPLA ₹121,326.0 Cr -0.1% 0.5% 1.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 3.2% 11.8% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,345.0 Cr 3.4% 0.5% 12.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.5%

-5.3%

-8.3%

SENSEX

0.3%

0.7%

8.8%


You may also like the below Video Courses